Skip to content
akaturk Academic measurement
Sign in Register
2025 SJR Q2 JCR Q2 · 2,7 OA

Journal detail

Integrated Blood Pressure Control

Publisher
Dove Medical Press Ltd
Country
New Zealand · Pacific Region
Type
journal
ISSN
  • 11787104
Scopus 0,575 SJR
Scopus Q2 SJR Q
WoS Q2 JCR Q
WoS 2,7 JIF
Scopus 32 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,575
  • Quartile Q2
  • H-Index 32
  • Cites/doc 1,8
  • Docs (3y) 30
  • Cites (3y) 64

Clarivate

Web of Science · JCR · 2024

  • JCR Q Q2
  • JIF 2,7
  • 5Y JIF 3,2
  • JCI 0,53

Subject classification

Categories (SJR)

  • Cardiology and Cardiovascular Medicine Q2
  • Internal Medicine Q2

Areas

  • Medicine

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q2 — 0,575 — — — — 32
2024 Q2 Q2 0,852 2,7 3,2 0,53 Q3 30
2023 Q2 Q3 0,583 1,5 2,8 0,4 Q3 30
2022 Q2 — 0,625 2,2 3,7 0,43 Q3 30
2021 Q2 — 0,635 — — 0,49 Q3 30
2020 Q2 — 0,652 — — 0,49 Q3 30
2019 Q2 — 0,811 — — — — 30
2017 Q2 — 0,865 — — — — 30
2016 Q1 — 1,17 — — — — 30
2015 Q2 — 0,694 — — — — 30
2014 Q2 — 0,49 — — — — 30
2013 Q2 — 0,395 — — — — 30
2012 Q3 — 0,151 — — — — 30
2011 Q3 — 0,175 — — — — 30
2010 Q4 — 0,104 — — — — 30

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2024 PERIPHERAL VASCULAR DISEASE ESCI Q2 Q3 41/98
2023 PERIPHERAL VASCULAR DISEASE ESCI Q3 Q3 67/96
2022 PERIPHERAL VASCULAR DISEASE ESCI — Q3 —
2021 PERIPHERAL VASCULAR DISEASE ESCI — Q3 —
2020 PERIPHERAL VASCULAR DISEASE ESCI — Q3 —